This study pioneers halogen-bonding driven self-assembly for B/N/Cl-rich carbon nanosheets, achieving record energy density (225 Wh/kg) through defect engineering
Neuroendocrinology Letters, 25(6), 403-406
In the GLP-1 Drug Market, the Indication segment is primarily driven by Type 2 Diabetes, which holds the largest market share at 52% due to its high prevalence and increasing awareness of chronic disease management
In practice, we continue as long as the medicine is helping your glucose levels, weight and overall health, and as long as side effects are manageable and it remains affordable and available
Each isolate was identified using Pitt's classification to investigate their mycotoxins production, and 18 different mycotoxins were isolated
What degradation pathways affect GLP-1 peptide drugs